For more information on this initiative, please see our FAQs. UV TEAM BLUE For more information on this initiative, please see our FAQs.

For more information on this initiative, please see our FAQs. CI5151 CI TEAM ORANGE For more information on this initiative, please see our FAQs.

For more information on this initiative, please see our FAQs. TEAM ARCTIC GREEN For more information on this initiative, please see our FAQs.

For more information on this initiative, please see our FAQs. LC5159 LOW CURE TEAM ORANGE For more information on this initiative, please see our FAQs.

For more information on this initiative, please see our FAQs. UV TEAM PASSION RED For more information on this initiative, please see our FAQs.

When I dropped back to lower horsepower two-stroke motors, we started seeing failures,” said Brad Stahl, founder of Piranha.

For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative. 1.844.4AVIENT www.avient.com

We specialize in formulating sustainable solutions to meet our customers' toughest challenges, and I am proud of how well our team has delivered throughout the COVID-19 pandemic and recent supply chain disruptions." See Attachment 3 for a definition and summary of special items. See Attachment 3 for a definition and summary of special items.

See Annex C for examples of information that may be considered Inside Information. Summary of Federal Securities Law Requirements: The federal securities laws impose criminal and civil penalties on persons and corporations that (a) buy or sell a company’s stock or other securities while in possession of Inside Information (note that this prohibition applies regardless of how you obtain the information and whether or not you consider the Inside Information when deciding to buy or sell the security); or (b) disclose Inside Information to another person who then trades in securities.

At Avient, we’ve built a culture of winning and how we do so is unique, lasting and difficult to replicate. It’s how we innovate best for them. We estimate in excess of $50 million dollars of new application sales by 2025, exclusively generated from the joining of our portfolios and technology teams.